新兴的心力衰竭生物标志物  

Emerging Biochemical Markers in Heart Failure

作　　者：蔡金[1] 黄全跃[1] 

机构地区：[1]中南大学湘雅二医院心内科,湖南长沙410001

出　　处：《心血管病学进展》2014年第1期31-34,共4页Advances in Cardiovascular Diseases

摘　　要：目前,心力衰竭的发病率和病死率高,成为了一个世界性的健康问题。心力衰竭的临床表现缺乏明显特异性,因而给其早期诊断及治疗造成一定困难。生物标志物反映了心力衰竭病理生理进程的不同方面,有助于心力衰竭的诊断、治疗及预后。随着各项技术的发展,出现了许多新型的生化标志物,现着重于现阶段新的心力衰竭生物标志领域的发展作一综述。Until recently, heart failure has been a global health issue with an increasing incidence and mortality of the disease. Owing to the lack of specific clinical manifestations of heart failure, the diagnosis and management is difficult. Biomarkers reflecting different patho physiological processes of heart failure, can assist in the diagnosis, therapy and prognosis of heart failure. With the development of technolo gies, novel markers are identified. This review highlights developments in the field of emerging heart failure markers.

关 键 词：生化标志物 心力衰竭 多配体蛋白聚糖-4 

分 类 号：R541.6[医药卫生—心血管疾病]